What Did The Government Know, And When Did Know It? US Supreme Court Seeks Views On False-Claims Case
Executive Summary
The US Solicitor General was asked to weigh in on Gilead's petition asking the high court to clarify application of its Escobar decision. Trade groups say FDA, not a jury, should decide whether a company has complied with the Food, Drug and Cosmetic Act.
You may also be interested in...
US Asks Supreme Court To Drop Gilead False Claims Case
The US Solicitor General is advising the Supreme Court not to hear a suit challenging whether a False Claims Act suit can be brought if the government knows about the alleged misbehavior and continues to pay for the relevant products or services.
High Court Won’t Take Up Off-Label Case; Other FCA Issues On Docket
While the Supreme Court announced this week that it won’t hear a case related to off-label billings, other False Claims Act-related suits may still be on the docket.
FCA Liability After Escobar: Challenges And Opportunities For Device Companies
A recent Supreme Court decision addressing the False Claims Act holds important implications for medical device companies, according to Gibson Dunn attorneys John D. W. Partridge, Jonathan M. Phillips and Reid F. Rector in this guest column.